A Randomized, Open-Label Phase III Trial to Evaluate the Efficacy and Safety of Bexarotene (Targretin) Capsules Combined With PUVA, Compared to PUVA Treatment Alone in Patients With Mycosis Fungoides.

Trial Profile

A Randomized, Open-Label Phase III Trial to Evaluate the Efficacy and Safety of Bexarotene (Targretin) Capsules Combined With PUVA, Compared to PUVA Treatment Alone in Patients With Mycosis Fungoides.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs Bexarotene (Primary) ; Methoxsalen
  • Indications Mycosis fungoides
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Nov 2012 New source identified and integrated (European Clinical Trials Database, EudraCT2004-003701-24).
    • 19 Jun 2012 Actual patient number 93 and additional trial location added as reported by ClinicalTrials.gov.
    • 19 Jun 2012 Planned end date 1 Jun 2011 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top